ong-term effect of dutasteride as add-on therapy for benign prostatic hyperplasia with persistent overactive bladder symptoms after treatment of alpha-1 blocker
Not Applicable
- Conditions
- Benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000032082
- Lead Sponsor
- Hokkaido Prefectural Esashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Use of antimuscarinic drug, beta-3 adrenergic agonist or antiandrogen drug
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overactive bladder symptom score
- Secondary Outcome Measures
Name Time Method